Inhibikase Therapeutics, INC. (IKT) SEC Filings — 2026
3 SEC filings for Inhibikase Therapeutics, INC. (IKT) in 2026.
Filings
- Inhibikase Therapeutics Files 8-K — 8-K · Apr 7, 2026
- Inhibikase Therapeutics Files S-8 for Employee Stock Plans — S-8 · Mar 26, 2026
- Inhibikase Kicks Off Phase 3 for PAH Drug IKT-001, Eyes $8.3B Market — 10-K · Mar 26, 2026